Preparation and drug release property of tanshinone IIA loaded chitosan-montmorillonite microspheres.

Int J Biol Macromol

College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, China. Electronic address:

Published: March 2019

In this study, a biocompatible chitosan/montmorillonite (CS/MMT) composite microsphere was developed as a carrier for loading and sustained-release of the hydrophobic drug of tanshinone IIA. Though the compatibility between hydrophobic drugs and hydrophilic matrix was fairly poor, tanshinone IIA was successfully loaded on the microsphere by the solvent exchange process during chitosan matrix dehydration. The microstructure of the resulting microspheres was characterized with several techniques, such as X-ray diffraction (XRD), thermo-gravimetric analysis (TGA), Fourier transform infrared spectroscopy (FT-IR), and scanning electron microscope (SEM). The results of drug loading and in vitro release study of the tanshinone IIA loaded CS/MMT composite microspheres showed that the incorporation of MMT into CS matrix would enhance the drug encapsulation and retard drug migration. The sample with mass ratio of CS: MMT (10:2) exhibited highest encapsulation efficiency (48.18% ± 2.54%) and slowest continuous cumulative release of drug in phosphate buffer solution (pH 7.4). It was found that the tanshinone IIA release kinetics fit the Higuchi model and the release mechanism was non-Fickian diffusion. Cell viability studies by CCK-8 assay showed that the microspheres showed no obvious cytotoxicity at the dosages below 80 μg/ml, and the MMT content had no significant effect on cell viability. This work provided a successful method of incorporating hydrophobic drugs into hydrophilic matrices, and has been successfully applied to the preparation of effective and biocompatible drug delivery for tanshinone IIA.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijbiomac.2018.12.072DOI Listing

Publication Analysis

Top Keywords

tanshinone iia
24
iia loaded
12
cs/mmt composite
8
hydrophobic drugs
8
drugs hydrophilic
8
cell viability
8
tanshinone
6
iia
6
drug
6
release
5

Similar Publications

Mechanisms and new advances in the efficacy of plant active ingredients in tendon-bone healing.

J Orthop Surg Res

January 2025

The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, No.41 Linyin Road, Baotou, Inner Mongolia, 014010, China.

The tendon-bone interface, known as the tenosynovial union or attachment, can be easily damaged by excessive exercise or trauma. Tendon-bone healing is a significant research topic in orthopedics, encompassing various aspects of sports injuries and postoperative recovery. Surgery is the most common treatment; however, it has limited efficacy in promoting tendon-bone healing and carries a risk of postoperative recurrence, necessitating the search for more effective treatments.

View Article and Find Full Text PDF

Tanshinone I Ameliorates Psoriasis-Like Dermatitis by Suppressing Inflammation and Regulating Keratinocyte Differentiation.

Drug Des Devel Ther

January 2025

Department of Dermatology, Second Xiangya Hospital, Hunan Key Laboratory of Medical Epigenomics, Clinical Medical Research Center of Major Skin Diseases and Skin Health of Hunan Province, Central South University, Changsha, Hunan, People's Republic of China.

Background: Psoriasis is an immune-related inflammatory systemic condition characterized by dysregulated keratinocyte proliferation and chronic inflammation. Tanshinone I (Tan-I) has recently been discovered to have immunomodulatory properties, but its role and mechanisms in treating psoriasis remain unclear.

Objective: To evaluate the efficacy of Tan-I in the treatment of psoriasis and to determine the mechanisms involved.

View Article and Find Full Text PDF

Introduction: The pathogenesis of renal fibrosis is related to blood stasis, and the method of promoting blood circulation and removing blood stasis is often used as the treatment principle. Danshen injection (DSI) is a commonly used drug for promoting blood circulation and removing blood stasis in clinic. However, whether DSI slows the progression of renal fibrosis or the potential mechanism is uncertain.

View Article and Find Full Text PDF

Plant Compounds Inhibit the Growth of W12 Cervical Precancer Cells Containing Episomal or Integrant HPV DNA; Tanshinone IIA Synergizes with Curcumin in Cervical Cancer Cells.

Viruses

December 2024

Department of Rehabilitation and Regenerative Medicine, College of Physicians and Surgeons, Columbia University, HHSC-1518, 701 W. 168th Street, New York, NY 10032, USA.

This study explores the effects of plant compounds on human papillomavirus (HPV)-induced W12 cervical precancer cells and bioelectric signaling. The aim is to identify effective phytochemicals, both individually and in combination, that can prevent and treat HPV infection and HPV associated cervical cancer. Phytochemicals were tested using growth inhibition, combination, gene expression, RT PCR, and molecular docking assays.

View Article and Find Full Text PDF

Preparation of pH-Responsive Tanshinone IIA-Loaded Calcium Alginate Nanoparticles and Their Anticancer Mechanisms.

Pharmaceutics

January 2025

State Key Laboratory for Macromolecule Drugs and Large-Scale Manufacturing, College of Pharmacy, Wenzhou Medical University, Wenzhou 325035, China.

Tanshinone IIA (Tan IIA) is a lipophilic active constituent derived from the rhizomes and roots of (Danshen), a common Chinese medicinal herb. However, clinical applications of Tan IIA are limited due to its poor solubility in water. : To overcome this limitation, we developed a calcium alginate hydrogel (CA) as a hydrophilic carrier for Tan IIA, which significantly improved its solubility.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!